Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Accumulation of neuronal α-synuclein is a prominent feature in Parkinson’s disease. More recently, such abnormal protein aggregation has been reported to spread from cell to cell and exosomes are considered as important mediators. The focus of such research, however, has been primarily in neurons. Given the increasing recognition of the importance of non-cell autonomous-mediated neurotoxicity, it is critical to investigate the contribution of glia to α-synuclein aggregation and spread. Microglia are the primary phagocytes in the brain and have been well-documented as inducers of neuroinflammation. How and to what extent microglia and their exosomes impact α-synuclein pathology has not been well delineated. We report here that when treated with human α-synuclein preformed fibrils, exosomes containing α-synuclein released by microglia are fully capable of inducing protein aggregation in the recipient neurons. Additionally, when combined with microglial proinflammatory cytokines, these exosomes further increased protein aggregation in neurons. Inhibition of exosome synthesis in microglia reduced α-synuclein transmission. The in vivo significance of these exosomes was demonstrated by stereotaxic injection of exosomes isolated from α-synuclein preformed fibrils treated microglia into the mouse striatum. Phosphorylated α-synuclein was observed in multiple brain regions consistent with their neuronal connectivity. These animals also exhibited neurodegeneration in the nigrostriatal pathway in a time-dependent manner. Depleting microglia in vivo dramatically suppressed the transmission of α-synuclein after stereotaxic injection of preformed fibrils. Mechanistically, we report here that α-synuclein preformed fibrils impaired autophagy flux by upregulating PELI1, which in turn, resulted in degradation of LAMP2 in activated microglia. More importantly, by purifying microglia/macrophage derived exosomes in the CSF of Parkinson’s disease patients, we confirmed the presence of α-synuclein oligomer in CD11b+ exosomes, which were able to induce α-synuclein aggregation in neurons, further supporting the translational aspect of this study. Taken together, our study supports the view that microglial exosomes contribute to the progression of α-synuclein pathology and therefore, they may serve as a promising therapeutic target for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α-syn species, potentially further contributing to this spread [158].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“Ultimately, the activation of microglia by these protein aggregates creates a feed-forward vicious cycle that aggravates neurodegeneration as activated microglia contribute to the propagation of tau, Aβ, α-synuclein, and TDP-43 into unaffected brain regions.159–164”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein can also activate glial cells by binding to TLR261,294,295 and enhance the spreading of α-synuclein.70,296”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“They achieved this by isolating exosomes derived from microglia/macrophages in the CSF of PD patients. In doing so, they successfully detected the presence of α-syn oligomer in CD11b + exosomes.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
The cited source says what the claim attributes to it.
In the citing paper
“Another research conducted by Guo et al. showed that microglial exosomes contribute to the progression of α-syn pathology [148].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedCeramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Autophagy is a vital pathway by which a-syn is degraded (Webb et al., 2003; Cuervo et al., 2004; Lee et al., 2004).”
BackgroundElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Research works printed but not linked: 1
- Yun X, Guoxin Z, Chao H, Kai M, Xingfang G, Fang W, et al. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 2019; 10: 174. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 401–500 of 553
Yao, C., Yu, J., Xie, D., Zhang, S., Tao, J., Kong, L., Fang, L., Zhu, Q., & Fang, M. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s598699 · Cited by 3
Exosomes as a Future Diagnostic Tool for Brain Disorders
Bhawale, R., Vasave, R., & Mehra, N. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-8373-5_14 · Cited by 3
Coronin1A Regulates the Trafficking of Alpha Synuclein in Microglia
Biggs, K. E., Fikse, E. N., Anderson, F. L., Kettenbach, A. N., & Havrda, M. C. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1337-24.2025 · Cited by 3
Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy
Akbar, M. U., Guo, W., Shen, X. M., Fang, Y., Liu, Y., Wang, P., Elnathan, R., & Chen, Y. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500124 · Cited by 4
Xu, L., Guo, Y., Dong, R., Wang, B., & Bi, Y. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.935869 · Cited by 3
The Current Proceedings of PSC-Based Liver Fibrosis Therapy
Li, M., Wu, Q., & Tam, P. K. H. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10592-4 · Cited by 4
1-L Transcription in Parkinson's Disease
Nahálka, J. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2811292 · Cited by 3
Serum alpha-synuclein in restless legs syndrome
Tahanis, A., Hashem, V. I., & Ondo, W. G. (2024) · SLEEP · doi:10.1093/sleep/zsae217 · Cited by 3
Kumar, S., Sinclair, J. A., Shi, T., Chuang, H.-S., Senapati, S., & Chang, H.-C. (2024) · bioRxiv · doi:10.1101/2024.08.17.607528 · Cited by 3
Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025) · Biology · doi:10.3390/biology14121787 · Cited by 2
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α -syn species, potentially further contributing to this spread [158].”
Qiu, H., Zhang, M., Li, M., Chen, C., Wang, H., & Yue, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062644 · Cited by 2
Dual Role of Exosomes in Parkinson's Disease: Adenine Exerts a Beneficial Effect
Chen, L., Shao, Y., Geng, J., Liu, H., Liu, Q., Cheng, Y., & Sun, T. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70331 · Cited by 2
Guan, J., Wang, X., Huang, Z., Huang, J., & Sun, D. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163857 · Cited by 2
Çelik, P. A., Derya-Andeden, M., & Dönmez‐Altuntaş, H. (2025) · Ege Tıp Dergisi · doi:10.19161/etd.1581447 · Cited by 2
Protein Misfolding in the Pathogenesis and Diagnosis of Neurodegenerative Diseases (Review)
Tregub, P. P., Kolotyeva, N. A., Chekulayev, P. A., Groshkov, A. A., Illarioshkin, S. N., Salmina, A. B., & Пирадов, М. А. (2025) · Современные технологии в медицине · doi:10.17691/stm2025.17.4.06 · Cited by 2
Tiny Messengers, Huge Consequences: Extracellular Vesicles and mTOR Signaling in Neuroinflammation
Garcia‐Segura, P., Chicote‐González, A., Espasa‐Marco, A., Garcia‐Alcaraz, M., Mora‐Bernabé, L., Abelló‐Fernández, M., & Malagelada, C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70256 · Cited by 2
Franck, L., Valek, L., Hahnefeld, L., Trautmann, S., Angioni, C., Weyer, M.-P., Thomas, D., Gurke, R., Wittig, I., Geißlinger, G., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01690-9 · Cited by 2
Islam, A. W., Rao, Z. K., Wilkhoo, H. S., Singh, B., Hussain, S., & Kadam, S. (2026) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2026.1004137 · Cited by 2
Qi, S., Shao, Y., Fan, R., Zhang, X., Hao, P., Wan, Y., & Luo, J. (2026) · Journal of Membrane Science · doi:10.1016/j.memsci.2026.125513 · Cited by 2
Sharma, R., Song, B. S., Rane, R., Paul, D., Singh, B., Verma, T., Mishra, A., Karan, A., & Song, J. J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119297 · Cited by 3
Bawne, G., Coenen, L., Nutma, E., Middeldorp, J., & Lorenowicz, M. J. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70272 · Cited by 2
Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
Lopez, D. M., Keavey, L., & Bowles, K. R. (2026) · Bioscience Reports · doi:10.1042/bsr20250131 · Cited by 2
The Dual Role of Glial Extracellular Vesicles in Neurodegeneration: Insights from iPSC-Based Models
Scrivo, A., Bernardino, L. I., & Consiglio, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125182 · Cited by 2
Exosomes: A new frontier in the treatment of neurological diseases
(51274), X. L., Chen, H., Xu, P., Guo, X., Gao, J., Yao, D., Wang, Y., Wang, T., Liu, B., & Yuan, J. (2026) · iScience · doi:10.1016/j.isci.2026.116331 · Cited by 2
Advances in biomarkers for Parkinson’s disease: from molecular pathology to precision diagnostics
Li, X., Chen, H., Wang, X., Hu, Y., Yang, Z., & Wei, M. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500789 · Cited by 2
Biphasic Role of Microglia in Healthy and Diseased Brain
Kumar, M., Arora, P., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_18 · Cited by 3
Artificial Exosomes as Targeted Drug Delivery Systems
Tsakiri, M., Naziris, N., Mahairaki, V., & Demetzos, C. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-12658-1_5 · Cited by 3
Ivanova, O., & Karelina, T. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13223 · Cited by 2
Recent updates on immunotherapy in neurodegenerative diseases
Salunkhe, J., & Ugale, R. R. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149205 · Cited by 2
Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
Rodríguez-Carreiro, S., Nogales, M. D. C., Jiménez-Galán, D., Carmona-Lorenzo, S., Caro-Martín, A., Navarro, E., & Esteras, N. (2024) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-24-00005 · Cited by 4
EXOSOMES AS MEDIATORS OF NEUROINFLAMMATION IN PARKINSON'S DISEASE: A REVIEW
Sheikh, M., Saiyyad, A., & Jirvankar, P. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i3.53756 · Cited by 2
Extracellular Vesicles as Intercellular Communication Vehicles in Regenerative Medicine
Gașpar, B. S., Ionescu, R. F., Enache, R. M., Dobrică, E.-C., Maria, C. S., Crețoiu, D., & Voinea, S. C. (2022) · Physiology · doi:10.5772/intechopen.101530 · Cited by 3
Perspective Chapter: Exosomes – The Surreptitious Intercellular Messengers in the Body
Soni, N., Jangra, J., Chaudhary, M., Nandi, G., & Bissa, B. (2023) · Physiology · doi:10.5772/intechopen.110779 · Cited by 3
Emerging autophagic endo-lysosomal targets in the management of Parkinson's disease
Siddiqui, T., & Bhatt, L. K. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.07.007 · Cited by 3
Special issue: Neuroinflammatory pathways as treatment targets in brain disorders
Chen, Z., Hu, W., & Fukunaga, K. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105271 · Cited by 2
García-Contreras, M., Lima, C., Alsop, E. B., Kaszala, B., Meechoovet, B., Purnell, B. A., Jiang, N., Saftics, A., Tang, C., Walsh, O. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.30.684535 · Cited by 2
Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C
Короленко, Т. А., Pupyshev, A. B., Беличенко, В. М., Tikhonova, M. A., & Amstislavskaya, T. G. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040128 · Cited by 1
Model fusion for predicting unconventional proteins secreted by exosomes using deep learning
Zhang, Y., Yu, L., Yang, M., Han, B., Luo, J., & Jing, R. (2024) · PROTEOMICS · doi:10.1002/pmic.202300184 · Cited by 1
The Role of Microglia in Parkinson's Disease and Possible Therapeutic Targets
Gomes, G. F., Galvão, S. L., Ventura, C., Lessa, Y. P. N., & dos Santos, J. C. C. (2024) · Brazilian Journal of Clinical Medicine and Review · doi:10.52600/2965-0968.bjcmr.2025.3.1.bjcmr11 · Cited by 1
Zhou, L., Wu, Z., Yi, X., Xie, D., Wang, J., & Wu, W. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119905 · Cited by 1
Self-citationSun, Q., Wu, M., Xie, R., Lai, L., Chen, Q., & Guan, J. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00008 · Cited by 1
Recent advances on the role of exosomes in neurodegenerative diseases
Bu, C.-T., Zhu, X., Zhang, Q., & Wenya, S. H. A. O. (2025) · Chinese Journal of Chromatography · doi:10.3724/sp.j.1123.2024.10035 · Cited by 2
Yin, M., Zhang, Y., Cheng, Z., Wu, Z., Luo, Q., & Chen, W. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115703 · Cited by 1
Pathological and Functional Brain Amyloids: A New Concept Explaining the Differences
Galkin, A. P., Mitkevich, V. A., Makarov, A. А., Valina, A. A., & Sysoev, E. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110459 · Cited by 1
Involvement of microglial aging in neurodegenerative diseases: a focus on Parkinson’s disease
Ballotto, L., Kaur, G., Bubacco, L., Civiero, L., & Greggio, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00006-1 · Cited by 1
Li, Y., Sun, C., & Liu, Q. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0007 · Cited by 1
Akintayo, C. O., Onyekweli, S. O., Omoruyi, G. O., & Akintayo, J. O. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-7437-6.ch013 · Cited by 1
Shen, Q., Lv, A., Li, Y., Liu, P., Yang, J., Wang, S., & Guo, H. (2026) · Neurogastroenterology & Motility · doi:10.1111/nmo.70289 · Cited by 1
Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations
Padilla, A. L., Lanciego, J. L., Vila, M., de Castro, F., Pozo, D., de Fonseca, F. R., Serrano, A., Sáez‐Valero, J., Núñez, L., Villalobos, C., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.031 · Cited by 1
Mukherjee, A. M. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00259-4 · Cited by 1
Therapeutic Mechanisms of Stem Cell–Derived Exosomes for Neurological Disorders: An Overview
Lin, C., Qi, L., Gao, X., Hu, L., Qian, B., Deng, Y., Zhou, C., Wang, C., Liu, G., Ding, Q., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05877-x · Cited by 1
Yang, Q., Shi, J., Xu, L., Zhao, G., Chen, Y., Cheng, L., Li, X., 孙志刚, & Huang, S. (2026) · MedComm · doi:10.1002/mco2.70798 · Cited by 2
Zafar, S., & Schneider, J. S. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01427-3 · Cited by 1
Qiu, X., Wang, Z., Xu, R., Hu, Y., & Le, W. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70991 · Cited by 1
Dong, X., Tan, H., Song, L., Jiang, B., Wu, Y., Duan, L., Yang, S., Zhang, H., Zou, Z., Zhang, W., et al. (2026) · Physics of Life Reviews · doi:10.1016/j.plrev.2026.07.004 · Cited by 1
Valenza, A., Pensabene, D., Rendina, F., Muzzi, M., Fracassi, A., Moreno, S., & Segatto, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1895046 · Cited by 1
Brain macrophages in neurodegeneration
Johnston, R. J., Torres, N. A. P., Li, Y., & Han, C. Z. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.06.005 · Cited by 1
The critical role of microglia in the stress response
Chen, K., Xuan, Z.-Y., Sun, B.-Y., Zhong, G.-N., Sun, X.-L., & Yan, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106894 · Cited by 1
Exosomes: Mechanisms, Diagnosis, and Therapeutic Progress in Vascular Cognitive Impairment
Wu, Z., & Kong, N. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06161-8 · Cited by 1
Palmas, M. F., Aminzadeh, K., Runfola, M., Parekh, P., Porcedda, C., Tweedie, D., Casula, L., Cardia, M. C., Marongiu, J., Etzi, M., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01549-8 · Cited by 1
Preclinical models based on endogenous neurotoxins
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00011-3 · Cited by 2
de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 2
Origin, Diversity, and Roles of Microglia
Ris, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_9-1 · Cited by 1
Role of Microglia in Parkinson’s Disease Pathology
Ciolac, D., & González‐Escamilla, G. (2024) · Neuromethods · doi:10.1007/978-1-0716-4083-8_4 · Cited by 1
MicroRNAs Fine-Tune Brain and Body Communication in Health and Disease
Henshall, D. C. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-89525-8_12 · Cited by 2
Torrente, D., Su, E. J., Schielke, G. P., Warnock, M., Stevenson, T. K., Mann, K. M., Vivien, D., & Lawrence, D. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4059525 · Cited by 1
Niskanen, J., Peltonen, S., Ohtonen, S., Fazaludeen, M. F., Luk, K. C., Giudice, L., Koıstınaho, J., Malm, T., Goldsteins, G., Albert, K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4021601/v2 · Cited by 4
Yadav, A., Vacchi, E., Pinton, S., Lazzarini, E., Pecoraro, M., Raimondi, A., Barile, L., Kaelin‐Lang, A., & Melli, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.10.709299 · Cited by 1
Proteomic analysis of subcellular compartments containing disseminated alpha-synuclein seeds
Kasahara, J., Imamura, Y., Hiyama, A., Yamanaka, T., Miyazaki, H., & Nukina, N. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.11.009
Alpha-synuclein spreading mechanisms in Parkinson's disease: The role of membrane receptors
Brás, I. C., & Outeiro, T. F. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.002
Investigating the role of neutral sphingomyelinases in membrane vesicle trafficking
Choezom, D. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9238 · Cited by 2
MicroRNAs and epigenetic processes in FSE-provoked epilepsy
Henshall, D. C., & Brennan, G. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89932-1.00016-0
Implication du récepteur de mort Fas dans la formation et la sécrétion de vésicules extracellulaires
Servant, Z. (2023) · theses.fr (ABES) · doi:10.70675/806a7bffzaf30z4270zaed8z5434904da10e
Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C
Короленко, Т. А., Pupyshev, A. B., Беличенко, В. М., Tikhonova, M. A., & Amstislavskaya, T. G. (2023) · Нейрохимия · doi:10.31857/s102781332304012x
Carnel-Amar, N. (2022) · theses.fr (ABES) · doi:10.70675/3d35389ez75a4z47aazba1fz438e4fc4b87b
Role of tPA in Central Nervous System Pathologies: From Ischemic Stroke to Parkinson's Disease
Quintero, D. (2022) · Deep Blue (University of Michigan) · doi:10.7302/6158
Origin, Diversity, and Roles of Microglia
Ris, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_9
Exosomes for Ophthalmic Therapeutics
Tao, H., & Li, Z. (2012) · Springer eBooks · doi:10.1007/978-981-97-5536-3_10
Role of extracellular vesicles in neurodegenerative diseases
Pahwa, H., Mukherjee, A. G., Gopalakrishnan, A. V., Vyas, N., Pandey, V., & Wanjari, U. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23891-8.00016-0
Shao, W., Liu, X., Chen, L., Xuedong, Z., Wu, Q., Bu, C., Zheng, F., Yu, G., Hu, H., Guo, Z., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5147375
Xu, H., Mo, L., Cha, Z., Ge, L., Zou, T., Gao, H., Yan, L., Yang, Y., Chen, X., Huo, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6578878/v1
Human- and Rodent-derived Extracellular Vesicles Mediate the Spread of Pathology in MSA-like ModelsPreprint
Vetsi, M., Dionysopoulou, D., Mavroeidi, P., Arvanitaki, F., Tsaka, G., Lopez, H. M., Giannopoulou, M., Fortis, S. P., Kriebardis, A. G., Becker, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.12.653337
Epigenetic Regulation Mediating Immunopathology in Parkinson’s Disease
Khan, S. S., & Khatri, D. K. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_13 · Cited by 1
Extracellular Vesicles as Biomarkers of Alzheimer Disease and Related Dementias
Mianoor, Z., Phelps, J., & Badhwar, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_18
Cai, Q., Jing, Q., Shi, G., Liu, Y., Gong, L., Chen, N., & Huang, M. (2026) · Toxicology · doi:10.1016/j.tox.2026.154500
Liu, K., & Wang, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03152-8
Exosomes as a Double-Edged Sword in Neurodegenerative Diseases: Roles and Engineering Strategies
Liu, R. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au27718
Vijay, A., & Varshney, R. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2790-8_3
Pan, T., Yuan, L., Zhao, R., Lu, L., Zhi, Y., Li, Y., Wu, M., & Huang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70044
Roy, I., Fiorini, M., Thomas, R. A., Ambriz, G. J., Farhan, S. M. K., Piscopo, V. E. C., & Durcan, T. M. (2026) · BMC Genomic Data · doi:10.1186/s12863-026-01462-2
Exosomes: New biomarker and therapeutic candidates in autism spectrum disorder research
Ünal, D., & Özgüven, A. S. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.10047 · Cited by 1
Lü, N., Wang, Y., Lu, Y., Lü, F., & Liu, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05468-2
Amo‐Aparicio, J., Daly, J., Højen, J. F., & Dinarello, C. A. (2024) · Figshare · doi:10.6084/m9.figshare.26599028
Fan, C., Wang, W., Yu, Z., Wang, J., Xu, W., Ji, Z., He, W., Hua, D., Wang, W., Yao, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25940094
Self-citationFriend or Foe: How glial cells interfere with prion-like spreading
Iycattil, A. (2023) · Journal of High School Science · doi:10.64336/001c.84219
Zhang, Y., Miao, Y., Xiong, X., Tan, J., Han, Z., Chen, F., Lei, P., & Zhang, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23512723
Wang, P., Lan, G., Xu, B., Yu, Z., Tian, C., Lei, X., Meissner, W. G., Feng, T., Yang, Y., & Zhang, J. (2024) · Figshare · doi:10.6084/m9.figshare.26612756
Serrano‐Marín, J., Marín, S., Bernal‐Casas, D., Lillo, A., González-Subías, M., Navarro, G., Cascante, M., Sánchez-Navés, J., & Franco, R. (2023) · Figshare · doi:10.6084/m9.figshare.24741892
Metadata
- Authors
- Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K.
- Affiliations
- Fudan University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Florida International University (US)
- Corresponding author
- Dong, Qiang
- Cui, Mei
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-01
- Volume
- 143
- Issue
- 5
- Pages
- 1476-1497
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC7241957
- OpenAlex
- W3022628169
- Cited by
- 522
- References
- 70
- Citations by year
- 2026: 76 · 2025: 103 · 2024: 102 · 2023: 84 · 2022: 84 · 2021: 60 · 2020: 12
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971013, 81870915, 81571109, 81571232)
- Science and Technology Commission of Shanghai Municipality (16411970200)
- National Institute of Environmental Health Sciences (R01-ES022274, R35-ES030523)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Parkinson's disease, alpha-synuclein, protein aggregation, prion-like spread, neuroinflammation, autophagy, PELI1, LAMP2, nigrostriatal degeneration, microglia depletion, therapeutic target
- MeSH terms
- Animals, Brain, Humans, Mice, Inbred C57BL, Neurons, Parkinson Disease, Microglia, Mice, alpha-Synuclein, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.